146 related articles for article (PubMed ID: 30474842)
1. IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence.
Innes AJ; Gil J
Methods Mol Biol; 2019; 1896():83-92. PubMed ID: 30474842
[TBL] [Abstract][Full Text] [Related]
2. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
3. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype.
Hari P; Millar FR; Tarrats N; Birch J; Quintanilla A; Rink CJ; Fernández-Duran I; Muir M; Finch AJ; Brunton VG; Passos JF; Morton JP; Boulter L; Acosta JC
Sci Adv; 2019 Jun; 5(6):eaaw0254. PubMed ID: 31183403
[TBL] [Abstract][Full Text] [Related]
4. Normal human fibroblasts are resistant to RAS-induced senescence.
Benanti JA; Galloway DA
Mol Cell Biol; 2004 Apr; 24(7):2842-52. PubMed ID: 15024073
[TBL] [Abstract][Full Text] [Related]
5. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation.
Wang P; Han L; Shen H; Wang P; Lv C; Zhao G; Niu J; Xue L; Wang QJ; Tong T; Chen J
Proc Natl Acad Sci U S A; 2014 May; 111(21):7683-8. PubMed ID: 24828530
[TBL] [Abstract][Full Text] [Related]
8. The role of hypoxia inducible factor-1 alpha in bypassing oncogene-induced senescence.
Kilic Eren M; Tabor V
PLoS One; 2014; 9(7):e101064. PubMed ID: 24984035
[TBL] [Abstract][Full Text] [Related]
9. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Phosphoproteome Reveals Prolyl Isomerase PIN1 as a Modulator of Oncogene-Induced Senescence.
Mohallem R; Aryal UK
Mol Cell Proteomics; 2024 Feb; 23(2):100715. PubMed ID: 38216124
[TBL] [Abstract][Full Text] [Related]
11. The protein kinase D1-mediated classical protein secretory pathway regulates the Ras oncogene-induced senescence response.
Su Y; Wang P; Shen H; Sun Z; Xu C; Li G; Tong T; Chen J
J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29420297
[TBL] [Abstract][Full Text] [Related]
12. Controversial aspects of oncogene-induced senescence.
Bianchi-Smiraglia A; Nikiforov MA
Cell Cycle; 2012 Nov; 11(22):4147-51. PubMed ID: 23095636
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence.
Garnett S; de Bruyns A; Provencher-Tom V; Dutchak K; Shu R; Dankort D
Mol Cancer Res; 2021 May; 19(5):874-885. PubMed ID: 33500359
[TBL] [Abstract][Full Text] [Related]
14. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
15. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation.
Kohli L; Kaza N; Coric T; Byer SJ; Brossier NM; Klocke BJ; Bjornsti MA; Carroll SL; Roth KA
Cancer Res; 2013 Jul; 73(14):4395-405. PubMed ID: 23722551
[TBL] [Abstract][Full Text] [Related]
16. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.
Lesina M; Wörmann SM; Morton J; Diakopoulos KN; Korneeva O; Wimmer M; Einwächter H; Sperveslage J; Demir IE; Kehl T; Saur D; Sipos B; Heikenwälder M; Steiner JM; Wang TC; Sansom OJ; Schmid RM; Algül H
J Clin Invest; 2016 Aug; 126(8):2919-32. PubMed ID: 27454298
[TBL] [Abstract][Full Text] [Related]
17. Coordinated post-transcriptional control of oncogene-induced senescence by UNR/CSDE1.
Avolio R; Inglés-Ferrándiz M; Ciocia A; Coll O; Bonnin S; Guitart T; Ribó A; Gebauer F
Cell Rep; 2022 Jan; 38(2):110211. PubMed ID: 35021076
[TBL] [Abstract][Full Text] [Related]
18. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.
Cipriano R; Kan CE; Graham J; Danielpour D; Stampfer M; Jackson MW
Proc Natl Acad Sci U S A; 2011 May; 108(21):8668-73. PubMed ID: 21555587
[TBL] [Abstract][Full Text] [Related]
20. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
